Abstract: The invention relates to 5-substituted alkylaminopyrazole derivatives of the formula: or salts thereof, wherein the various symbols are as defined in the description, to processes for their preparation, to compositions thereof, and to their use for the control of pests (including arthropods and helminths).
Type:
Application
Filed:
August 21, 2004
Publication date:
March 29, 2007
Applicant:
Bayer CropScience S.A.
Inventors:
David Chou, Werner Knauf, Uwe Doller, Karl Seeger
Abstract: The present invention relates to new DNA sequences encoding an insecticidal Cry9Fa protein and insecticidal parts thereof, which are useful to protect plants from insect damage. Also included herein are micro-organisms and plants transformed with a DNA sequence encoding an insecticidal Cry9Fa protein and processes for controlling insects and to obtain a plant resistant to insects.
Type:
Application
Filed:
November 17, 2006
Publication date:
March 29, 2007
Applicant:
BAYER BIOSCIENCE N.V.
Inventors:
Annemie Boets, Nicole Damme, Eva Mathieu, Stijn Vanneste, Jeroen Van Rie
Abstract: The present invention relates to recombinant nucleic acid molecules which contain two or more nucleotide sequences which encode enzymes which participate in the starch metabolism, methods for generating transgenic plant cells and plants which synthesize starch which is modified with regard to its phosphate content and its side-chain structure. The present invention furthermore relates to vectors and host cells which contain the nucleic acid molecules according to the invention, the plant cells and plants which originate from the methods according to the invention, to the starch synthesized by the plant cells and plants according to the invention, and to processes for the preparation of this starch.
Abstract: The invention provides a human GPR85 which is associated with the cardiovascular disorders, hematological disorders, inflammatory diseases, metabolic diseases, neurological disorders, urological disorders, respiratory diseases, cancer disorders and reproduction disorders. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, hematological disorders, inflammatory diseases, metabolic diseases, neurological disorders, urological disorders, respiratory diseases, cancer disorders and reproduction disorders. The invention also features compounds which bind to and/or activate or inhibit the activity of GPR85 as well as pharmaceutical compositions comprising such compounds.
Type:
Application
Filed:
October 19, 2004
Publication date:
March 29, 2007
Applicant:
BAYER HEALTHCARE AG
Inventors:
Stefan Golz, Ulf Bruggemeier, Andreas Geerts, Holger Summer
Abstract: The invention relates to substituted dihydroquinazolines and to processes for their preparation and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses.
Type:
Grant
Filed:
April 26, 2004
Date of Patent:
March 27, 2007
Assignee:
Bayer HealthCare AG
Inventors:
Tobias Wunberg, Judith Baumeister, Ulrich Betz, Mario Jeske, Thomas Lampe, Susanne Nikolic, Jürgen Reefschläger, Rudolf Schohe-Loop, Frank Süssmeier, Holger Zimmermann, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Jörg Keldenich, Dieter Lang, Peter Nell
Abstract: High-solids binder combinations comprising polyisocyanates, special lactone-based polyols and polyacrylate-polyols, a process for preparing such binders, and their use for producing coatings. The lactone-based polyols include ?-caprolactone-based polyols having an average hydroxy functionality ?2 and a number-average molecular weight of from 119 to 2000 g/mol. The polyacrylate resins are prepared by copolymerizing optionally functional polybutadienes, aromatic monomers, hydroxyalkyl esters of acrylic or methacrylic acid having primary hydroxyl groups, aliphatic esters of acrylic or methacrylic acid and C1 to C8 monoalcohols, ?,?-unsaturated C3–C7 monocarboxylic or dicarboxylic acids or of one or more monoesters of maleic acid or fumaric acid and C1 to C14 monoalchols.
Type:
Grant
Filed:
May 14, 2004
Date of Patent:
March 27, 2007
Assignee:
Bayer MaterialScience AG
Inventors:
Christian Wamprecht, Markus Mechtel, Jörg Tillack, Thomas Klimmasch
Abstract: Nucleic acid molecules are described encoding a starch granule-bound protein as well as methods and recombinant DNA molecules for the production of transgenic plant cells and plants synthesizing a modified starch with modified viscosity properties and a modified phosphate content. Moreover, the plant cells and plants resulting from those methods as well as the starch obtainable therefrom are described.
Abstract: The present invention relates to a solid formulation comprising a) one or more sulfonamides, b) one or more surfactants, and c) at least 2% by weight of water. The solid formulation is suitable for the field of crop protection.
Abstract: A readhead for illuminating a sample carrier and receiving light from the sample carrier, including a housing for receiving a sample carrier, an array of light sources mounted within the housing in a fixed position relative to the sample carrier, and including first and second light-emitting diodes for emitting substantially monochromatic light of a two different wavelengths, a light guide mounted in the housing between the light-emitting diodes and the sample carrier, and a light detector coupled to receive light from the sample carrier. The readhead also includes a light source for directing excitation light of a predetermined wavelength to the sample carrier, and a light filter positioned between the sample carrier and the light detector and adapted to prevent passage therethrough of the excitation light. The readhead allows both fluorescence spectroscopy and reflectance spectroscopy to be conducted on the sample carrier.
Abstract: The present invention relates to hetaryl-substituted pyrazolidine derivatives of the formula (I) in which Het, A, D and G are as defined above, to a plurality of processes for their preparation and to their use as pesticides and/or herbicides. Moreover, the invention relates to selective herbicidal compositions comprising both the hetaryl-substituted pyrazolidinedione derivatives and a crop plant compatibility-improving compound.
Type:
Application
Filed:
July 12, 2004
Publication date:
March 22, 2007
Applicant:
BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Inventors:
Reiner Fischer, Lutz Assmann, Stefan Lehr, Mark Drewes, Dieter Feucht, Olga Malsam, Guido Bojack, Thomas Auler, Martin Hills, Heinz Kehne, Christian Arnold
Abstract: The present invention relates to the area of blood clotting. The invention relates in particular to certain heterocyclic compounds, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases.
Type:
Application
Filed:
May 6, 2004
Publication date:
March 22, 2007
Applicant:
BAYER HEATHCARE AG
Inventors:
Christoph Gerdes, Elisabeth Perzborn, Jens Pohlmann, Susanne Rohrig, Alexander Straub, Christian Thomas, Arounarith Tuch, Karl-Heinz Schlemmer
Abstract: The imvention relates to 5-sub-stituted-oxyalkylaminopyrazole derivatives of formula (I) or salts thereof wherein the various symbols are as defined in the description, to processes for their preparation, to compositions thereof, and to their use for the control of pests (including arthropods and helminths).
Type:
Application
Filed:
August 21, 2004
Publication date:
March 22, 2007
Applicant:
BAYER CROPSCIENCE S.A.
Inventors:
David Chou, Stefan Schnatterer, Werner Knauf, Karl Seeger
Abstract: The present invention relates to gene expression profiles, microarrays comprising nucleic acid sequences representing gene expression profiles, and methods of using expression profiles and microarrays. The invention also provides methods and compositions for diagnostic assays for detecting cancer and therapeutic methods and compositions for treating cancer. The invention also provides methods for designing, identifying, and optimizing therapeutics for cancer.
Abstract: The invention provides a human 5-HT4 which is associated with the cardiovascular disorders, gastrointestinal and liver diseases, inflammatory diseases, hematological disorders, respiratory diseases, neurological disorders and urological disorders. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, gastrointestinal and liver diseases, inflammatory diseases, hematological disorders, respiratory diseases, neurological disorders and urological disorders. The invention also features compounds which bind to and/or activate or inhibit the activity of 5-HT4 as well as pharmaceutical compositions comprising such compounds.
Type:
Application
Filed:
May 12, 2004
Publication date:
March 22, 2007
Applicant:
BAYER HEALTHCARE AG
Inventors:
Stefan Golz, Ulf Bruggemeier, Andreas Geerts
Abstract: What is described are herbicidal compositions comprising herbicidal compounds of the formula (I) and a compound of the formula (II) which acts as a safener. In the formulae (I) and (II), the symbols R1 to R17 denote hydrogen, halogen, nitro and various organic radicals. These herbicidal compositions have a particularly high compatibility with useful plants.
Type:
Application
Filed:
September 28, 2006
Publication date:
March 22, 2007
Applicant:
Bayer CropScience GmbH
Inventors:
Frank Ziemer, Hermann Bieringer, Christopher Rosinger, Erwin Hacker, Lothar Willms
Abstract: The present invention relates to a process for preparing 4-(4-aminophenyl)-3-morpholinone by reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that the reaction is effected in an aliphatic alcohol.
Type:
Application
Filed:
September 9, 2004
Publication date:
March 22, 2007
Applicant:
Bayer HealthCare AG
Inventors:
Christian Thomas, Mathias Berwe, Alexander Straub
Abstract: The present invention relates to new substituted benzimidazoles, their preparation and their use as agents against parasitic protozoa. The active compounds are characterized by the following formula (I): in which X1 represents chlorine or bromine, R1 represents hydrogen or C1-4-alkyl, R3 represents fluoroalkyl, R2 represents the radical R4 represents alkyl or substituted phenyl, R5 represents alkyl.
Type:
Application
Filed:
November 17, 2006
Publication date:
March 22, 2007
Applicant:
Bayer Aktiengesellschaft
Inventors:
Gisela Greif, Axel Haberkorn, Bernd Baasner, Folker Lieb, Albrecht Marhold
Abstract: The invention describes a process for the production of aromatic amines by the catalytic hydrogenation of aromatic nitro compounds, with the process being characterized by at least one catalytic hydrogenation step and the catalyst consists at least of a monolithic support and a catalytically active coating.
Type:
Grant
Filed:
October 7, 2004
Date of Patent:
March 20, 2007
Assignee:
Bayer MaterialScience AG
Inventors:
Peter Lehner, Thomas Turek, Matthias Brandt, Susanne Buchholz
Abstract: By means of a new process for the resolution of racemic 3-aminopentanenitrile, enantiomerically enriched 3-aminopentanenitrile or its salts can be obtained. For this, racemic 3-aminopentanenitrile is reacted with an enantiomerically enriched organic acid and one of the two diastereomeric salts formed is separated off and then converted into the enantiomerically enriched 3-aminopentanenitrile or its salts.